Home > Insider Trading > Filing (0001179110-14-013296)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1121702	Metabolix Inc.	MBLX	Miscellaneous Plastics Products (3080)	043158289

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1377833	Johan Walsem Van	C/O Metabolix, Inc. 21 Erie Street Cambridge MA 02139	Chief Operating Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-08-22	300,000	$0.00	332,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B Convertible Preferred Stock	Acquisiton	2014-08-22	300	$0.00	300,000	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
300			No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	26,637	Indirect	By 401k Plan

Footnotes

The reported securities are included within 300,000 units of Issuer securities (the "Units") purchased by the reporting person for $0.50 per Unit pursuant to a Securities Purchase Agreement, dated August 4, 2014 by and among the Issuer and certain other qualified institutional and individual investors (the "Purchase Agreement").
Each Unit consists of one share of the Issuer's common stock, par value $0.01 per share ("Common Stock") and one one-thousandth (1/1,000) of a share of the Series B Preferred Stock.
Shares acquired as Company matching contributions under the Metabolix, Inc. 401(k) Plan.
Each share of Preferred Stock will automatically convert into 1,000 shares of Common Stock upon the effectiveness of the filing of an amendment to the Issuer's charter to increase the number of shares of the Issuer's authorized Common Stock to not less than 150,000,000.